Abstract. Activating mutations in KIT have been identified in melanomas of acral and mucosal types and in those arising in chronically sun-damaged skin. Until now, KIT has been considered an oncogenic driver and a potential therapeutic target.
What is C kit a marker for?
Measuring the amount of c-kit in tumor tissue may help diagnose cancer and plan treatment. C-kit is a type of receptor tyrosine kinase and a type of tumor marker. Also called CD117 and stem cell factor receptor.
What is NRAS melanoma?
NRAS was the first melanoma oncogene to be identified in 1984 in a screen of melanoma cell lines for genes that possessed transforming properties and were identified as activating mutations in NRAS in 4/30 samples.
What genes are mutated during melanoma?
To date, 2 genes have been primarily linked to familial melanoma; they are called CDKN2A and CDK4. A mutation (alteration) in either of these genes gives a person an increased risk of melanoma. However, alterations in these 2 genes only account for a small percentage of familial melanoma.
What is a CKIT mutation?
Mutations in the KIT gene are the most common genetic changes associated with gastrointestinal stromal tumors (GISTs). GISTs are a type of tumor that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine.
What does c-Kit mean?
Biomarker Abbreviation: c-Kit. Definition: tyrosine-protein kinase Kit, also known as CD117 or mast/stem cell growth factor receptor (SCFR) – a proto-oncogene that interacts with cell growth factors, c-Kit plays a role in cell survival, multiplication and differentiation.
Is KIT the same as c-Kit?
KIT is a receptor tyrosine kinase type III, which binds to stem cell factor (a substance that causes certain types of cells to grow), also known as “steel factor” or “c-kit ligand”.
Is BRAF positive melanoma more aggressive?
Even though BRAF-positive melanomas can be more aggressive, many factors can affect the risk of your melanoma coming back.
What does BRAF stand for in medical terms?
BRAF is a human gene that encodes a protein called B-Raf. The gene is also referred to as proto-oncogene B-Raf and v-Raf murine sarcoma viral oncogene homolog B, while the protein is more formally known as serine/threonine-protein kinase B-Raf.
Who is most susceptible to melanoma?
Melanoma is more likely to occur in older people, but it is also found in younger people. In fact, melanoma is one of the most common cancers in people younger than 30 (especially younger women).
Is melanoma dominant or recessive?
In fair-complexioned individuals worldwide, the majority of melanoma cases are related to environmental factors such as excessive ultraviolet radiation (sun exposure). However, about 5-10% of melanoma cases are inherited in an autosomal dominant fashion.
What does c-kit mean?
What is the pathophysiology of c-KIT mutations in melanoma?
Although accounting for only 3% of all melanomas, mutations in c-KIT are mostly derived from acral, mucosal, and chronically sun-damaged melanomas. As an important factor for cell differentiation, proliferation, and survival, inhibition of c-KIT has been exploited for clinical trials in advanced melanoma.
What is the role of c-KIT in cancer?
c-Kit, a receptor tyrosine kinase, is involved in intracellular signaling, and the mutated form of c-Kit plays a crucial role in occurrence of some cancers. The function of c-Kit has led to the concept that inhibiting c-Kit kinase activity can be a target for cancer therapy.
Which c-kit inhibitors are best for advanced melanoma?
Finally, several therapeutic trials of c-KIT inhibitors, including imatinib, dasatinib, nilotinib, and sunitinib, will be analyzed for their success rates and limitations in advanced melanoma treatment.
Is c-KIT an oncogene or receptor tyrosine kinase?
This paper presents the findings of previous studies regarding c-Kit as a receptor tyrosine kinase and an oncogene, as well as its gene targets and signaling pathways in normal and cancer cells. The c-Kitgene location, protein structure, and the role of c-Kit in normal cell have been discussed.
